Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up

Primary hyperoxaluria type 3

MONDO:0013327

Primary hyperoxaluria type 3 (PH3) is a disorder of glyoxylate metabolism that can be asymptomatic or characterized by oxalate nephrolithiasis.

Also known as: HOGA1 primary hyperoxaluria, primary hyperoxaluria caused by mutation in HOGA1, primary hyperoxaluria type III, HP3, PH III, hyperoxaluria, primary, type 3, hyperoxaluria, primary, type III

2 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (680) Metabolic disease (233) Hereditary disease (176) Inborn errors of metabolism (45) Human disease (14) Primary hyperoxaluria (12) Carbohydrate metabolism disease (3) Disease of genetic or genomic mechanism (2) Inborn carbohydrate metabolic disorder (2) Disease by developmental or physiological process (0)
Not yet finished but already full! 1 Completed 1
Sort by
  • Promising drug may protect kidneys in kids with rare oxalate disorder

    Disease control Completed

    This study tested a monthly injection called nedosiran in 27 children from birth to 11 years old with primary hyperoxaluria, a rare condition that causes harmful oxalate buildup and kidney damage. The goal was to see if the drug safely lowers oxalate levels in the urine. Early re…

    Phase: PHASE2 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control

    Last updated Jun 27, 2026 12:08 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space